TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 1,148,777,709
- Total 13F shares
- 607,728,519
- Share change
- +38,578,733
- Total reported value
- $9,874,096,775
- Put/Call ratio
- 19%
- Price per share
- $16.25
- Number of holders
- 528
- Value change
- +$630,049,704
- Number of buys
- 271
- Number of sells
- 176
Quarterly Holders Quick Answers
What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 881624209:
Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
3.8%
|
43,704,401
|
$616,669,092 | — | 31 Mar 2024 | |
| Ion Asset Management Ltd. |
13F
|
Company |
3.4%
|
38,578,487
|
$544,342,451 | — | 31 Mar 2024 | |
| Phoenix Financial Ltd. |
13F
|
Company |
3%
|
34,581,787
|
$488,081,116 | — | 31 Mar 2024 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
2.6%
|
29,857,800
|
$421,294,000 | — | 31 Mar 2024 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
2.5%
|
28,794,366
|
$406,063,000 | — | 31 Mar 2024 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
2.4%
|
28,128,744
|
$396,896,578 | — | 31 Mar 2024 | |
| Slate Path Capital LP |
13F
|
Company |
2.3%
|
26,896,184
|
$379,505,156 | — | 31 Mar 2024 | |
| Lingotto Investment Management LLP |
13F
|
Company |
2.3%
|
26,424,535
|
$372,850,189 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
1.8%
|
21,248,407
|
$299,815,028 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
1.5%
|
17,669,588
|
$249,317,887 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
16,223,272
|
$228,910,368 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.94%
|
10,748,785
|
$151,665,356 | — | 31 Mar 2024 | |
| AustralianSuper Pty Ltd |
13F
|
Company |
0.88%
|
10,112,070
|
$140,658,894 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
8,102,722
|
$113,897,125 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.67%
|
7,697,163
|
$108,607,000 | — | 31 Mar 2024 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
7,501,284
|
$105,843,117 | — | 31 Mar 2024 | |
| SOUND SHORE MANAGEMENT INC /CT/ |
13F
|
Company |
0.65%
|
7,494,690
|
$105,750,076 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.55%
|
6,345,808
|
$89,539,351 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.52%
|
6,025,169
|
$85,015,135 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.47%
|
5,425,620
|
$76,555,513 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.44%
|
5,110,126
|
$72,103,878 | — | 31 Mar 2024 | |
| PointState Capital LP |
13F
|
Company |
0.44%
|
5,104,969
|
$72,031,113 | — | 31 Mar 2024 | |
| Parsifal Capital Management, LP |
13F
|
Company |
0.44%
|
5,048,300
|
$71,231,513 | — | 31 Mar 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
0.43%
|
4,962,456
|
$70,020,254 | — | 31 Mar 2024 | |
| Maple Rock Capital Partners Inc. |
13F
|
Company |
0.38%
|
4,363,401
|
$61,567,588 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.37%
|
4,215,216
|
$59,476,698 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.36%
|
4,161,857
|
$58,723,801 | — | 31 Mar 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.35%
|
4,029,716
|
$56,859,293 | — | 31 Mar 2024 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.32%
|
3,630,768
|
$51,230,132 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.31%
|
3,617,747
|
$51,046,409 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.31%
|
3,572,529
|
$50,408,385 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.31%
|
3,543,860
|
$50,003,871 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.31%
|
3,537,284
|
$49,911,078 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.3%
|
3,486,440
|
$49,193,668 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.29%
|
3,344,800
|
$47,195,128 | — | 31 Mar 2024 | |
| Capital International Investors |
13F
|
Company |
0.28%
|
3,185,719
|
$44,950,495 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.27%
|
3,121,998
|
$44,051,392 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.26%
|
3,007,618
|
$42,437,489 | — | 31 Mar 2024 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.24%
|
2,769,864
|
$39,082,781 | — | 31 Mar 2024 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.24%
|
2,762,154
|
$38,973,993 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
2,636,066
|
$37,194,891 | — | 31 Mar 2024 | |
| Grantham, Mayo, Van Otterloo & Co. LLC |
13F
|
Company |
0.21%
|
2,433,267
|
$34,333,397 | — | 31 Mar 2024 | |
| FIL Ltd |
13F
|
Company |
0.21%
|
2,396,583
|
$33,815,786 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.19%
|
2,223,464
|
$31,373,077 | — | 31 Mar 2024 | |
| Tri Locum Partners LP |
13F
|
Company |
0.19%
|
2,216,188
|
$31,270,413 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
2,198,202
|
$31,016,631 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.19%
|
2,159,333
|
$30,468,189 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.19%
|
2,142,332
|
$30,228,305 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.18%
|
2,072,506
|
$29,243,060 | — | 31 Mar 2024 | |
| GOLDENTREE ASSET MANAGEMENT LP |
13F
|
Company |
0.18%
|
2,058,650
|
$29,047,552 | — | 31 Mar 2024 |
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.